Biocracked
Approach: conceptual metaphor. Palette: D, bold color field.

A single brass pocket-scale balance sits at the center of a saturated mustard-yellow seamless backdrop, shot straight-on from slightly below at eye level. Its two pans hang almost perfectly level. One pan holds a small pile of pale, matte white powder, and the other holds a similar pile, so the tiny, nearly equal difference reads at a glance. A thin electric green thread is tied around the balance's pointer, a subtle accent. Soft, large-window studio light comes from the left and casts a crisp, short shadow to the right on the glossy surface below. Shallow depth of field blurs the background edges. The mood is quiet, skeptical and unresolved, with a clean, editorial look. No text, numerals or markings are visible on the scale.
Longevity

Rapamycin Ta Gasa Babban Gwajin Tsawon Rayuwa a Ɗan Adam – Menene Sakamakon?

Dr. Synapse · · 4 min read

Idan ka bi labarin rapamycin a matsayin maganin tsawon rai, wannan sakamakon zai iya baka mamaki: binciken da ya fi girma a duniya kan dogon amfani da rapamycin a mutane bai nuna wani fa'ida a tsawon rai ba. Amma ka karanta cikakken bayani kafin ka yanke hukunci. Mutanen da aka bincika sun sha bambanci da ‘yan bio‑hacker da ke amfani da ƙananan ƙuduri na lokaci‑lokaci.

Babban Bayanin Sakamako

A wani takarda da aka wallafa a Geroscience, Darren Stewart (NYU Langone Health) da William Fitzsimmons (University of Illinois at Chicago) sun yi amfani da bayanan ƙasa da ƙasa na rijistar masu canjin koda a Amurka. Sun kwatanta:

  • 4,885 marasa lafiya da aka ba da rapamycin bayan canjin koda (mai hana mTOR)
  • 6,589 marasa lafiya da ba a ba da rapamycin ba

An bi su tsawon shekaru 11 na matsakaici, kuma 6,443 daga cikinsu suka mutu a lokacin binciken. Dukkaninsu sun kai shekara guda bayan canjin koda tare da graft da ke aiki.

Bayan da aka yi amfani da propensity score weighting, shekarun rayuwa na matsakaici sun kasance 64.6 a ƙungiyar da ke sha rapamycin, kuma 64.3 a ƙungiyar da ba su sha ba. Tsakanin ‑1.6 zuwa +2.0 shekaru ne ke cikin 95 % na ƙarfin amincewa. Marubutan sun kammala da cewa "ba mu ga wani haɓaka mai ma'ana a tsawon rai ba tare da hana mTOR ba."

Manbobi: PubMed 42989006 | DOI 10.1007/s11357-026-02643-8

Dalilin Da Ya Sa Binciken Ya Mahimmanci

Rapamycin na ɗaya daga cikin magungunan da ake ɗauka a matsayin ɗan takarar tsawon rai, amma yawanci hujjojin suna fitowa ne daga gwaje‑gwajen dabbobi da ƙananan nazarin kan mutum. Wannan takarda ita ce ɗaya daga cikin manyan nazarin da aka yi a kan dogon amfani da rapamycin a mutane, inda aka yi la’akari da dubunnan mutuwar da suka faru maimakon alamun gajeren lokaci.

Masu binciken sun daidaita shekarun marasa lafiya, nauyi (BMI), cutar suga da wasu abubuwa guda 15. Wannan yana da muhimmanci saboda waɗanda likita ya ba da magani su kan bambanta sosai da waɗanda ba su samu ba.

Manyan Gargadi (Karanta Wadannan Kafin Ka Yanke Shawara)

1. Wannan ƙungiya ce ta masu canjin koda. Dukkan marasa lafiya suna da canjin koda kuma suna amfani da magungunan rage garkuwar jiki. Yanayin asali da dalilan mutuwarsu ba su dace da na masu sha'awar tsawon rai masu lafiya ba. Wataƙila rapamycin zai taimaka wa tsufar da ke da matsalar graft, amma ba ya nuna tasiri a kan mutanen da ba su da irin wannan yanayi.

2. Amfanin rapamycin a nan na nufin rage garkuwar jiki. A cikin canjin koda, rapamycin ana ba da shi don rage ƙarfi garkuwar jiki da kare graft. Wannan daban yake da ƙuduri na ƙananan lokuta da 'yan bio‑hacker ke tattaunawa. Takardar ba ta gwada ko tallafa wa wani tsarin tsawon rai ba, don haka kada ka ɗauke ta a matsayin hujja ga ƙuduri na lokaci‑lokaci.

3. Binciken na observational ne. Ko da an daidaita bambance‑bambancen da aka auna, ba za a iya kawar da duk wani ɓoyayyen rikitarwa ba. Marasa lafiya na iya samun rapamycin saboda wasu dalilan likita da ka iya karkatar da sakamakon.

4. Bambancin shekaru na ‑1.6 zuwa +2.0 ba ya nufin babu tasiri kwata‑kwata. Wannan yana nufin ba a samu babbar riba ba, amma ba ya kawar da yiwuwar ƙananan tasiri a wasu fannoni.

5. Zaɓin masu tsira. An ƙara kawai marasa lafiya da ke da graft mai aiki bayan shekara guda, don haka binciken ba ya magana kan tasirin rapamycin a matakin farko bayan canjin koda.

Menene Wannan Ke Nufi Ga Masu Sha'awar Kudin Lokaci‑Lokaci Don Tsawon Rai?

  • Fatan da ba a samu ba. Idan rapamycin na da tasiri mai ƙarfi a kan tsawon rai a mutane, za a ga shi a cikin rukuni mai girma kamar wannan. A wannan ƙungiyar, ba a ga irin wannan tasiri ba.
  • Har yanzu tambaya ce mara amsa. Hujjojin da suka fi ƙarfi kan tasirin rapamycin a tsawon rai suna fitowa ne daga gwaje‑gwajen dabbobi. Shin ƙananan ƙuduri na lokaci‑lokaci a cikin mutane masu lafiya zai canza rayuwa ko lafiyar su, har yanzu ba a gwada ba.
  • Kada a yanke hukunci da sauri. Wannan bincike ba ya tabbatar da ko ƙwarai da gaske yana da tasiri, kuma ba ya kawar da yiwuwar amfanin da ba a gano ba.

Abubuwan Da Za Ka Iya Yi Da Su A Aiki

  • Kuduri da lokaci: Takardar ba ta ba da wani ƙuduri na tsawon rai ba, kuma babu wani ƙuduri da aka tabbatar da tasirinsa a rayuwar mutum. Duk wanda ke tunanin amfani da rapamycin ya kamata ya yi hakan tare da likita da zai sa ido kan lafiyarsa.
  • Wanda zai iya sha'awa: Masu lafiya masu sha'awar geroscience, musamman a ƙarƙashin kulawar likita, su ne mafi dacewa da wannan bayanin.
  • Wanda ya kamata ya guje shi: Masu canjin koda kada su canza maganin rage garkuwar jiki da kansu. Duk wanda ke da cututtukan da ke hulɗa da rapamycin (misali, cutar ƙwayar cuta, ciwon hanta) ya kamata ya nemi shawarwarin likita kafin fara amfani da shi.
  • Sa ran tasiri: Rapamycin magani ne da ke gyara garkuwar jiki, amma binciken ya nuna babu fa'ida a kan tsira a wannan rukuni.

Muhimmancin Gabaɗaya

Wannan shi ne sakamako mai gaskiya, ba hukunci na ƙarshe ba. A cikin marasa lafiya 11,474 da aka yi wa canjin koda kuma aka bi su tsawon shekara 11, masu amfani da rapamycin da waɗanda ba su amfani da shi sun samu kusan daidai shekarun rayuwa (64.6 da 64.3). Zaɓin ƙungiya, ƙuduri da tsarin lura suna iyakance fassarar sakamakon. Ga masu sha'awar tsawon rai, darasin shi ne a ci gaba da kasancewa cikin hankali kuma a jira gwaje‑gwajen da za a gudanar a kan mutane masu lafiya.

The authors report consulting relationships with companies unrelated to this study and declare no competing interests.

Original study

Read the original research on pubmed.ncbi.nlm.nih.gov →

This article summarizes published research for general information. It is not medical advice.

DS

Written by

Dr. Synapse

Dr. Synapse writes for Biocracked: biohacking science, longevity & human performance.

Related Articles

Conceptual metaphor: a sheet of thick, clear laboratory glass standing upright, with a single hairline fracture running diagonally across it. A thin ribbon of vivid electric-green liquid seeps through the crack and drips onto a glossy white surface below. The glass is photographed straight on, at a slight low angle, in crisp macro focus along the fracture edges, where tiny chips catch the light. The backdrop is a seamless, saturated tomato-red field that fills the frame. Soft, directional studio light from the left creates bright refraction lines along the glass edge and a clean, warm-red tinted shadow on the right. The mood is tense but revealing, a long-held assumption starting to give way. Empty space on the right balances the composition. No text, no people, and no blue cast.
longevity

Rapamycin Ba Zai Iya Kai Zuwa Kwakwalwa Ba? Dalilin Da Yasa Wannan Karya Ke Karyewa

BY DR. SYNAPSE ·

Kalmar “Rapamycin ba zai iya shiga kwakwalwa ba” ta zama ruwan dare a tsakanin masu sha'awar tsawaita rai. Binciken sabo a mujallar *Journal of Alzheimer's Disease* ya nuna cewa hujjar da ke goyon bayan wannan maganar tana dogara ne kan hanyar gwaji marar inganci, kuma ƙarin shaidu na nuni da akasin haka. Wannan labarin yana tantance hujjojin da ke tallafawa, waɗanda ba su tallafawa ba, da kuma abin da masana ke bukatar su bincika a gaba.

Approach: conceptual metaphor, in palette D (bold color field).

A saturated mustard-yellow backdrop holds seven identical wooden-handled stopwatches in a staggered row, shot from a slightly raised three-quarter angle. Five stopwatches have run on and show tarnished, cloudy glass faces. The two in front have clean, glossy glass, and each carries a small electric green (#00e676) ribbon tied to its crown. The faces carry no numerals or readable marks. Soft, even studio light from a large overhead softbox gives gentle, short shadows. Shallow depth of field blurs the back of the row. The mood is playful but analytical, with crisp contrast between the dull watches and the bright pair. The image suggests that extra time and good time are not the same thing.
longevity

Sulforaphane da Metformin Sun Ci Nasara, Wasu Kayan Tsawon Rai Biyar Sun Fadi

BY DR. SYNAPSE ·

Kayan tsawon rai bakwai da aka gwada sun tsawaita rayuwar maza na ƙurarren ƙwaro a wani sabon bincike na GeroScience, amma biyu ne kawai suka ba da gudummawa ga lafiyar haihuwa. Sulforaphane da metformin su ne magungunan da suka inganta nasarar jima'i a ƙarshen rayuwa, alamar lafiyar haihuwa. Sauran guda biyar sun ƙara kwanaki ba tare da inganta wannan aikin ba, abin da ke nuna cewa tsawaita rayuwa da kiyaye ƙwarewa na iya rabuwa. Wannan bincike ya shafi ƙwaro ne kawai, ba ya nufin mutane, amma yana jaddada muhimmancin duba tasirin magunguna a kan aiki, ba kawai tsawon rayuwa ba.

Approach: macro science. Palette: bold color field (violet).

Extreme close-up of fisetin crystals, a small cluster of pale yellow needle-like flavonoid crystals with translucent, faceted edges, resting on a smooth glossy deep violet surface. The camera sits low at a shallow three-quarter angle with a very shallow depth of field, so the front crystals are razor sharp and the rest dissolves into soft magenta-violet blur. Lighting is a single crisp, slightly warm studio key from upper left that makes the crystal edges glow and throws long soft shadows across the violet. A few tiny electric green (#00e676) specks of reflected light catch on the crystal tips. The mood is precise, curious and quietly promising, like a sample under inspection, with plenty of clear violet space on the right side of the frame.
longevity

Fisetin, Senolytic, Ya Tsawaita Rayuwar Beraye—Babu Shaida a Kan Dan Adam

BY HELIX WARD ·

Fisetin, wani flavonoid na tsiro, ya bayyana a matsayin mafi ƙarfi a cikin senolytics daga cikin kwayoyi goma a wani bincike na 2018 da aka wallafa a EBioMedicine. A berayen da suka tsufa, maganin da aka ba su a baya‑bayan nan ya rage alamar senescence, ya rage cututtuka masu alaka da tsufa, kuma ya tsawaita tsawon rayuwar su na matsakaici da iyaka. Amma wannan sakamako na dabbobi ne kawai; har yanzu ba a kammala wani gwajin tsawon rai na mutane ba. Wannan labarin zai fayyace abin da masu binciken suka gano, ma’anar ƙimar da aka yi amfani da ita, da kuma waɗanda ya kamata su bi sahun yayin da ake ci gaba da gwaje‑gwajen ɗan adam.

Approach: conceptual metaphor. Palette: bold color field.

A single steel bathroom-style analog tape measure, pulled taut and wrapped around a ripe, glossy yellow-orange pear lying on its side, with the tape's tip locked at the same unmarked point, suggesting a waistline that did not shrink. The pear sits on a saturated magenta seamless backdrop, shot from a low three-quarter angle with a shallow depth of field, the stem sharp and the background softly blurred. Hard but slightly diffused studio key light from upper left casts a crisp, short shadow in deeper magenta on the surface. A tiny electric green sticky dot marks the tape's end, with no numbers or writing visible. Mood: playful, skeptical, deadpan, scientific restraint rather than hype.
longevity

Rapamycin Sau Daya a Kowane Mako na Shekara: Lafiya, Amma Shin Kitse na Ciki Ya Sauya?

BY REX MERIDIAN ·

Kowa na son sanin ko shan rapamycin sau ɗaya a mako zai rage kitse a cikin ciki kuma ya ƙara tsawon lokacin lafiya. Gwajin PEARL ya ba da amsoshi masu ban mamaki: bayan makonni 48 da aka yi wa manya masu lafiya, ba a ga wani canji a adadin kitse na ciki ba, kuma amincin maganin ya yi kama da na placebo. Wasu alamu na biyu – kamar ƙaruwa a ƙwayar ƙiba da rage radadi a mata masu sha 10 mg, da kuma jin daɗi mafi kyau a ƙungiyar 5 mg – suna nuna yiwuwar fa'ida, amma sakamakon na ƙananan rukuni ne kuma ba su tabbatar da tsawaita rayuwa ba. Ga abin da aka samu da abin da ba a samu ba.

This page is available in